Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2026 08:30 ET | Source: BioMedWire

Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world...
May 13, 2026 08:30 ET | Source: BioMedWire

CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Among the most guarded structures in human biology, the brain is also one of the hardest to treat. The blood-brain...
March 16, 2026 10:00 ET | Source: 24/7 Market News

Nvidia’s Bet on Digital Biology and Stocks That Could Ride the Wave

Recursion OS clinical trial Jensen Huang, NVIDIA’s (NASDAQ:NVDA) CEO, is now pointing to digital biology to be the next technological wave
May 31, 2022 14:14 ET | Source: Portnoy Law

AbbVie Inc. Investors: June 6, 2022 Last Day to Actively Participate in the Class Action Lawsuit; Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AbbVie Inc. (“AbbVie” or the...
May 25, 2022 20:42 ET | Source: Portnoy Law

AbbVie Inc. Investors: Last Days to Actively Participate in the Class Action Lawsuit; Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 25, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AbbVie Inc. (“AbbVie” or the...